Fibrant, the chemical supplier, announced that, due to commodity pricing, as well as global supply and demand dynamics, it will begin a wind down of its Augusta, Georgia plant and U.S. business, Fibrant, LLC. The wind down will take place over approximately 16 months, during which time Fibrant will meet all obligations to its employees, and serve the needs of its customers to the extent possible. The CPL plant capacity includes two lines that is 70 kta and 150 kta for each. DSM Caprolactam was renamed as Fibrant in January 2016. Following the recent transfer of DSM's global caprolactam business activities into a JV named ChemicaInvest with CVC Capital Partners, DSM Caprolactam will be renamed as Fibrant effective January 18, 2016. The company has a total CPL production capacity of more than 900 kta and over 1.5 mta of ammonium sulfate, while sales stood at USD 1,300 million in 2014. Established in 1952, DSM Caprolactam, a fully owned subsidiary of DSM, joined ChemicaInvest in July 2015 as an offshoot of DSM. On July 31, 2015, CVC and DSM announced that they had finalised their partnership for DSM's activities in Polymer Intermediates like CPL and acrylonitrile and also composite resins under the JV company. Fibrant begins in 1952, when we commissioned our first factory for the production of Caprolactam in The Netherlands. With a second facility in the US (Augusta, 1966) and a third in China (Nanjing, 2002), we became the first true global producer and supplier of high quality chemical performance products and services. In 2015, CVC Capital Partners acquired 65% of the business from DSM, which retained the remaining 35%.